DR. DANIEL Z BALMACEDA M.D.
NPI 1104919588
Internal Medicine - Pulmonary Disease in Overland Park, KS
Active since September 30, 2006
10550 QUIVIRA RD, SUITE 335, OVERLAND PARK, KS 66215(913) 599-3800(913) 599-3854 Get Directions Write a Review
About Dr. Daniel Z Balmaceda M.d. NPPES
Official registry information on file with the National Plan and Provider Enumeration System.
DR. DANIEL Z BALMACEDA M.D. (NPI 1104919588) is an individual pulmonary disease provider in Overland Park, Kansas, licensed in Kansas (0428744) and active in the NPI registry since September 2006.
NPPES Registry Identity
NPI1104919588
Entity TypeIndividualMale
Primary Taxonomy207RP1001X
Provider Legal NameDR. DANIEL Z BALMACEDACredential: M.D.
Location Address10550 QUIVIRA RD, SUITE 335Overland Park, KS 66215-2306
Mailing AddressPo Box 12035Kansas City, KS 66112-0035 · (913) 599-3800 · Fax (913) 599-3854
Phone(913) 599-3800
Fax(913) 599-3854
Sole ProprietorNo
Enumeration DateSeptember 30, 2006
Last NPPES UpdateJanuary 28, 2022
✔ NPI 1104919588 is a valid, active identifier and passes the ISO check-digit test.
Specialties & Licenses
★ Primary SpecialtyInternal Medicine · Pulmonary DiseaseAllopathic & Osteopathic Physicians
Taxonomy Code207RP1001X
License✔ Licensed in KS · 0428744
Definition
An internist who treats diseases of the lungs and airways. The pulmonologist diagnoses and treats cancer, pneumonia, pleurisy, asthma, occupational and environmental diseases, bronchitis, sleep disorders, emphysema and other complex disorders of the lungs.
10550 QUIVIRA RD, Overland Park, KS 66215
Other Identifiers 3
Medicaid1104919588MO
Medicaid100372270GKS
Medicaid100372270DKS
Accepted Insurance
The full list of accepted plans is on the Insurance tab. Issuers include Anthem Blue Cross and Blue Shield.Insurance ›
Areas of Expertise CMS Part B claims 13
Services this provider delivered to Medicare fee-for-service patients, from the CMS Medicare utilization data. Higher counts generally reflect more experience with a service; care delivered outside Medicare is not included.
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes 99233
Follow-up hospital inpatient care per day typically involves a 35-minute check-up by your healthcare provider. This service includes monitoring your health progress, adjusting your treatment plan if needed, and answering any questions you may have about your condition or care.
185 services72 patients
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes 99232
Follow-up hospital inpatient care involves daily check-ups while you're admitted in the hospital. Typically, a healthcare provider spends about 25 minutes each day reviewing your condition, adjusting treatment if needed, and answering any questions you might have.
109 services75 patients
Critical care, first 30-74 minutes 99291
Critical care involves immediate and constant attention by a team of specially-trained health professionals. It's for patients with life-threatening conditions, requiring first 30-74 minutes of intense monitoring and treatment.
84 services41 patients
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more 99213
This is a routine visit for patients who have already been seen by the healthcare provider. During this approximately 20-29 minute appointment, your health status will be evaluated and any necessary treatments or tests will be discussed. It's a chance to address any health concerns you may have.
57 services47 patients
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more 99214
This is a routine check-up for patients who have previously visited our clinic. It involves a comprehensive review of your health and any ongoing treatments. The consultation lasts between 30-39 minutes, allowing enough time to discuss any concerns.
55 services36 patients
New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more 99204
This is a first-time office or outpatient visit lasting between 45-59 minutes. The healthcare provider evaluates your health, discusses your medical history, and may suggest further tests or treatments. It's an opportunity to ask questions and understand your health better.
29 services29 patients
Medicare Quality Performance CMS QPP · MIPS
Performance in the CMS Quality Payment Program: the MIPS final score across four weighted categories, and the individual quality measures reported to Medicare.
Reported Quality Measures
Cervical Cancer Screening
Percentage of women 21-64 years of age who were screened for cervical cancer using either of the following criteria: - Women age 21-64 who had cervical cytology performed every 3 years - Women age 30-64 who had cervical cytology/human papillomavirus (HPV)…
16%122 patients
Colorectal Cancer Screening
Percentage of adults 50-75 years of age who had appropriate screening for colorectal cancer
26%318 patients2/55-star benchmark: 85%
Diabetes: Medical Attention for Nephropathy
The percentage of patients 18-75 years of age with diabetes who had a nephropathy screening test or evidence of nephropathy during the measurement period
80%85 patients4/55-star benchmark: 99%
e-Prescribing
At least one permissible prescription written by the MIPS eligible clinician is queried for a drug formulary and transmitted electronically using certified EHR technology.
70%81 patients1/55-star benchmark: 99%
Falls: Screening for Future Fall Risk
Percentage of patients 65 years of age and older who were screened for future fall risk during the measurement period
76%265 patients4/55-star benchmark: 99%
Medication Reconciliation
The MIPS eligible clinician performs medication reconciliation for at least one transition of care in which the patient is transitioned into the care of the MIPS eligible clinician.
100%29 patients5/55-star benchmark: 100%
Patient-Specific Education
The MIPS eligible clinician must use clinically relevant information from CEHRT to identify patient-specific educational resources and provide access to those materials to at least one unique patient seen by the MIPS eligible clinician.
54%78 patients3/55-star benchmark: 97%
Pneumococcal Vaccination Status for Older Adults
Percentage of patients 65 years of age and older who have ever received a pneumococcal vaccine
39%267 patients2/55-star benchmark: 90%
Preventive Care and Screening: Influenza Immunization
Percentage of patients aged 6 months and older seen for a visit between October 1 and March 31 who received an influenza immunization OR who reported previous receipt of an influenza immunization
29%373 patients2/55-star benchmark: 88%
Preventive Care and Screening: Screening for Depression and Follow-Up Plan
Percentage of patients aged 12 years and older screened for depression on the date of the encounter using an age appropriate standardized depression screening tool AND if positive, a follow-up plan is documented on the date of the positive screen
21%440 patients1/55-star benchmark: 96%
Provide Patient Access
At least one patient seen by the MIPS eligible clinician during the performance period is provided timely access to view online, download, and transmit to a third party their health information subject to the MIPS eligible clinician's discretion to withhold…
100%78 patients5/55-star benchmark: 100%
Secure Messaging
For at least one unique patient seen by the MIPS eligible clinician during the performance period, a secure message was sent using the electronic messaging function of CEHRT to the patient (or the patient-authorized representative), or in response to a secure…
12%78 patients1/55-star benchmark: 89%
Use of High-Risk Medications in the Elderly
Percentage of patients 65 years of age and older who were ordered high-risk medications. Two rates are submitted. 1) Percentage of patients who were ordered at least one high-risk medication.
Lower rates are better for this measure.
Patients 2+: 0% · 246 patients
0%246 patients5/55-star benchmark: 100%
View, Download, or Transmit (VDT)
At least one patient seen by the MIPS eligible clinician during the performance period (or patient-authorized representative) views, downloads or transmits their health information to a third party during the performance period.
15%78 patients
Providers report different measures because they deliver different services; reporting more or less information is not a reflection of quality. Star ratings appear only where CMS assigned them.
Other Providers at the Same Location NPPES 20
Providers registered at the same practice address, or within the immediate area, according to the NPPES registry.
Psychiatry & Neurology (Neurology)
10550 QUIVIRA RD, SUITE 530
OVERLAND PARK, KS 66215
OVERLAND PARK, KS 66215
Surgery (Surgical Oncology)
10550 QUIVIRA RD, SUITE 350
OVERLAND PARK, KS 66215
OVERLAND PARK, KS 66215
Internal Medicine (Pulmonary Disease)
10550 QUIVIRA RD, SUITE 480
OVERLAND PARK, KS 66215
OVERLAND PARK, KS 66215
Podiatrist (Foot & Ankle Surgery)
10550 QUIVIRA RD, SUITE 260
OVERLAND PARK, KS 66215
OVERLAND PARK, KS 66215
Frequently Asked Questions NPPES & CMS
Common questions about this NPI record, answered from the official NPPES registry and CMS datasets shown on this page.
What is Daniel Balmaceda's NPI number?
The NPI number for Daniel Balmaceda is 1104919588. It was assigned to this individual provider in the NPPES registry on September 30, 2006.
Where is Daniel Balmaceda located?
Daniel Balmaceda practices at 10550 Quivira Rd Suite 335, Overland Park, KS 66215. The listed phone number is (913) 599-3800.
What is Daniel Balmaceda's specialty?
The primary specialty registered for this NPI is Internal Medicine, specializing in Pulmonary Disease, with taxonomy code 207RP1001X.
What insurance does Daniel Balmaceda accept?
Health plans from Anthem Blue Cross and Blue Shield list Daniel Balmaceda as in-network in at least one marketplace plan. Coverage varies by plan and year; verify with the insurer or the provider before a visit.
When was this NPI record last updated?
The NPPES record for Daniel Balmaceda was last updated on January 28, 2022. NPI Profile syncs with the weekly NPPES data releases published by CMS.
